Delayed Gastric Emptying in Patients with Prader Willi Syndrome by Arenz, T. et al.
© Freund Publishing House Ltd., London Journal of Pediatric Endocrinology & Metabolism, 23, 867-871 (2010) 
 
VOLUME 23, NO. 9, 2010  867 
Delayed Gastric Emptying in Patients with Prader Willi Syndrome 
T. Arenz1, A. Schwarzer2, Th. Pfluger3, S. Koletzko2 and H. Schmidt2 
1Inselspital, Children’s Hospital of the University Berne, 2Dr. von Haunersches Kinderspital of the 
Ludwig-Maximilians-University of Munich, 3Department of Nuclear Medicine of the Ludwig-Maximilians-
University of Munich, Germany 
ABSTRACT 
Background: A 15 year old girl with Prader-
Willi Syndrome (PWS) died of gastric rupture. 
Systematic literature research revealed seven 
case reports of PWS patients with acute gastric 
dilatation, two had a lethal course. The objective 
of this study was to determine if delayed gastric 
emptying in PWS patients might contribute to 
gastric dilatation. 
Methods: Gastric emptying was measured in 
eight patients with PWS by nucleotid 
scintigraphy after a standardized test meal. 
Results: Median age was 17.8 years (range 10.1-
19.5). Median BMI of the male patients was 29.5 
(range 18.4-34.8), of the female patients 28 
(range 20.0-44.8). Half time of gastric emptying 
was delayed in five of the eight patients (median 
78.5 minutes, range 59-134). 
Conclusion: Scintigraphic measurement of 
gastric emptying in eight PWS patients revealed 
delay in comparison to normal values. This 
might be a risk factor for gastric dilatation and 
rupture in patients with PWS. 
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INTRODUCTION AND  
PATIENT REPORT 
 PWS is a rare genetic disorder characterized 
by muscular hypotonia, feeding difficulties 
during infancy and hyperphagia after the age of 
two to four years leading to obesity, short 
stature, as well as mental and motoric 
retardation1,2. As a severe gastrointestinal 
complication gastric rupture was reported by 
Wharton and colleagues3. We observed a 
similar dramatic course of the disease in a 15 
year old girl with PWS. She had been under 
hypocaloric diet and growth hormone treatment 
for ten years. She presented in a children’s 
hospital with abdominal pain. Acute 
gastroenteritis was suspected and symptoms 
were treated. After three days, the patient could 
be discharged without any complaints on a 
dietary food. Two days later abdominal pain 
recurred. One day later the patient was 
readmitted with an acute abdomen as well as 
symptoms of cardiovascular shock. Emergency 
surgery was performed which showed a huge 
and completely ruptured stomach without any 
signs of inflammation or ulceration. The girl 
died after two hours because of multiorgan 
failure. Histology showed no signs of 
inflammation, no H. pylori infection and no 
peptic ulcer, respectively. It was suspected that 
an ischaemic lesion of the stomach had led to 
the perforation. There was no previous episode 
of binge eating. We reviewed the literature and 
found a case series including six female and 
one male PWS patients suffering from gastric 
dilatation, two with lethal outcome3. The 
objective of this study was to measure gastric 
emptying in patients with PWS as a possible 
etiologic factor for acute gastric dilatation and 
necrosis. 
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PATIENTS AND METHODS 
Patients  
 In this clinical observation study, eight 
patients with genetically confirmed PWS, all on 
dietary treatment and regularly followed up in our 
outpatient clinics, were included.  
 Written informed consent of the patients 
and/or their parents was obtained. Patients did not 
take any medications and were not on growth 
hormone treatment (Table 1).  
 
TABLE 1 
Characteristics of eight patients with PWS and time of 
diagnosis 
Patient  Gender Age at diagnosis 
 of PWS [years] 
Genetic 
diagnosis  
1  F 0.2 del  
2  F 2.8 del  
3  M 13.0 del  
4  F 4.9 i.m.  
5  M 4.3 del  
6  M 5.3 mupd  
7  M 0.4 del  
8  F 5.0 del  
del = microdeletion chromosome 15  
i.m. = imprinting mutation mupd = maternal uniparental 
disomie  
BMI  
 For children and adolescents the percentiles 
for German children were used4, for adult PWS 
patients we used the references from the WHO5.  
Dietary treatment  
 All patients had a special hypocaloric and fat 
reduced diet (10 kcal/cm body length, 20% fat, 
55% carbohydrates, 25% protein)6,7. Median age 
at beginning of the diet was 14.5 years (range 2-
19). Seven of the eight patients were on this diet 
for at least one year and one patient started the 
diet six months before gastric emptying 
measurement, respectively.  
 
 
Gastric emptying  
 
 After an overnight fast of 12h, gastric 
emptying was measured by nucleotid scintigraphy 
after a liquid standardized test meal of 200 ml 
Frebini®
 
(Fresenius, 1 kcal/ml). For scintigraphic 
measurement Tc-99m-DTPA (Technicium-99m-
Diethylene Triamine Pentaacetic Acid) (20 MBq) 
was used as tracer.  
Scintigraphy technique  
 A dual headed gamma camera (Picker-Prism 
2000XP, Picker International, Cleveland, Ohio, 
USA) with a low energy collimator and interfaced 
with a computer was used for data acquisition. 
For the scintigraphy, the field of view was 
centred over the stomach where a region of 
interest was defined. The acquisition of images 
was started immediately after the ingestion of the 
test meal while the patients were placed in a 
supine position. Dynamic scanning was obtained 
over a time frame of up to 45 minutes. Residual 
activity in the stomach 30 minutes after ingestion 
of the test meal was measured and half emptying 
time (min) (t1/2s) of the stomach was calculated 
using established methods, as previously 
described8.  
 For the half emptying time in scintigraphic 
emptying testing a cut-off of t1/2s ≥60 min was 
chosen established by former studies9.  
RESULTS 
 The median age of the eight patients at gastric 
emptying measurement was 17.8 years (range 
10.1-19.5). Patients’ characteristics, anthropo-
metric data, and gastric emptying times are 
shown in Table 1 and Table 2. Three of the eight 
patients had normal weight, five of them fulfilled 
the criteria for obesity (adults: BMI>30 kg/m
2
, 
children: BMI > 97th percentile). Five patients 
showed delayed gastric emptying, and three 
values at the upper limit of normal, with a median 
time of 82 minutes (range 59-134).  
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TABLE 2  
Age, weight, BMI, BMI percentile and scintigraphic half time at time of gastric emptying measurement 
Patient  Age at 
 examination 
Weight BMI BMI Obesity Scintigraphic 
 half time 
 [years] [kg] [kg/m2] percentile  [minutes] 
1 15.3 43.00 22.9 83 no 90.0 
2 17.2 48.00 19.9 33 no 59.0 
3 19.4 81.2 30.2 99 yes 59.0 
4 17.6 74.6 33.0 > 100 yes 60.0 
5 17.9 68.9 28.71 98 yes 76.0 
6 19.1 89.0 34.8 > 100 yes 81.0 
7 10.2 37.2 18.4 72 no 99.0 
8 19.5 93.9 44.8 > 100 yes 134.0 
 
DISCUSSION 
Gastrointestinal manifestations in patients with 
PWS  
 This prospective study reports delayed and 
borderline gastric emptying in eight patients with 
PWS. Our results confirm the findings of Choe et 
al, who performed scinitigraphic gastric emptying 
studies with a standard meal of solid food in 
eleven children with PWS10. Another recent study 
found gastric emptying times in PWS similar to 
lean healthy controls but significantly increased 
compared to obese controls11. Sudden death after 
gastric rupture in patients with PWS has already 
been described by Wharton et al. They reported 
severe gastric dilatation in six female and one 
male patient. Two of the patients (23 and 37 
years) died after rupture. In two girls (six and 
seven years) gastric dilatation resolved 
spontaneously, while in the remaining patients 
(21, 27, and 36 years) subtotal gastrectomy had to 
be performed. The authors speculated that the risk 
for acute gastric rupture may increase with age 
after episodes of massive dilatation of the 
stomach. However, our patient was only 15 years 
of age with normal weight. Demographic and 
cause of death data from voluntary familial 
reporting on PWS patients reported another four 
male patients (17, 22, 24 and 49 years) with 
unexpected mortality due to gastric rupture and 
necrosis and an additional four patients with 
suspected gastric rupture as cause of death2. 
Causes of death were reported in 27 PWS 
patients12. In children younger than five years of 
age, they included hypoventilation, aspiration and 
acute respiratory failure due to infection; two 
children died after onset of gastrointestinal 
symptoms and high fever. In the age group older 
than nine years of age, the causes of death were 
mainly related to obesity but included two adult 
males with acute abdominal pain, one of them 
with severe gastric dilatation12. In summary, at 
least 4 of 27 patients with PWS had suffered from 
severe gastrointestinal symptoms before their 
sudden and unexpected death. As the blood 
supply of the stomach is very rich, including 
multiple collaterals from extensive intramural 
anastomoses3, ischaemic events normally are very 
rare. Gastrectomy and biopsy preparations 
reported by Wharton et al. showed diffuse 
mucosal infarction with multifocal transmural 
necrosis as well as vascular dilatation and small 
thrombi within, in the infarcted areas.  
Etiology of gastric dilatation  
 Hyperphagia could be one possible 
explanation for gastric dilatation in PWS patients. 
However, the published case reports3 and the 
history of our patient revealed no excessive food 
intake before the acute event. None of the cases 
in the literature was reported to take ulcerogenic 
drugs like NSAIDs or corticosteroids. However, 
four of six patients including our case were 
reported to have symptoms of acute infectious 
gastroenteritis before gastric rupture3. In PWS a 
disturbance of hypothalamic regulation (1) seems 
to be causal for a reduced parasympathic activity, 
leading to impaired temperature regulation and 
production of saliva. Furthermore patients with 
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PWS usually can not vomit1, 10.  
 Therefore we hypothesized that disturbed 
vagal activity could influence gastric emptying in 
PWS patients similar to patients with 
gastroparesis. This could be an explanation for 
gastric dilatation and in combination with the 
disturbance of sensibility for pain and extension 
of the stomach also an explanation for acute 
gastric rupture. It is not clear whether these 
patients have an increased feeling of hunger or 
decreased or even absence of a feeling of 
satiety11. In all cases described in the literature, 
gastric rupture was a sudden event without any 
previous alarming signs or symptoms3.  
 
TABLE 3 
Documented cases of death in PWS patients due to suspected gastric perforation/-rupture – literature review 
Age  Gender  BMI  Cause of death  Presenting 
 Symptoms  
Autopsy/ 




female  no data 
available  
gastric perforation 
and necrosis  
diffuse abdominal 
pain, vomiting  
distended and necrotic 
stomach, multiple 
subdiaphragmatic abscesses  





male  22 kg/m2  gastric perforation 
and necrosis  
abdominal pain 
and vomiting  
microscopic foci of mucosal 
ulceration extending to full 
necrosis and perforation  





male  27 kg/m2  gastric perforation 
and necrosis  
abdominal pain 
and vomiting  
transmural gastric necrosis 
and focal mucosal ulceration 
of the esophageus  





male  53,5 kg  subsequent gastric 
rupturte  





male  50,2 
kg/m2  
“ulcer“ with gastric 
rupture 









and vomiting  
markedly distended 
abdomen with a gastric tear 
and a „paper-thin“ stomach 
wall  





female  36 kg/m2  suspected gastric 
rupture/and or 
necrosis  
hematemesis  markedly distended stomach 
with erosive gastritis and 
evidence of chronic gastritis  


















male  38 kg/m2  suspected gastric 
rupture/and or 
necrosis  





Diagnostic and therapeutic consequences  
 Patients with PWS are known to have an 
increased threshold for pain. Furthermore they are 
usually unable to vomit. Both are contributing 
risk factors to gastric dilatation and rupture and 
therefore vomiting and abdominal pain in these 
patients should be taken especially serious as they 
are very rare. There should be a prompt 
diagnostic work-up and careful observation in 
these patients. As perception of pain is impaired 
in PWS, analgetic medication should be used 
carefully, not to mask any symptoms. 
Furthermore, medications with gastrointestinal 
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side effects as NSAIDs and steroids should be 
avoided. Acceleration of gastric emptying by 
procinetic agents like domperidon or metro-
clopramide might be an option in symptomatic 
patients with delayed gastric emptying. However, 
further studies are needed to show whether there 
is any clinical effect and whether episodes of 
gastric dilatation may be prevented by these 
interventions.  
CONCLUSION  
 Scintigraphic measurement of gastric emptying 
in eight PWS patients revealed delayed gastric 
emptying in comparison to normal adult values. 
Delayed gastric emptying might be a risk factor 
of gastric dilatation and rupture in patients with 
PWS.  
 Further studies should evaluate contributing 
pathophysiological mechanisms and potential 
prevention of this fatal complication.  
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